The Muhammadu Buhari-led Federal Government on Monday admitted indicating interest to be part of the global solidarity trial of vaccines being tried to tackle coronavirus (COVID-19).
The world health body had launched solidarity drug trials for these specific drugs – hydroxychloroquine, chloroquine phosphate, and remdesivir – in April.
Speaking to newsmen last Friday during the presidential task force (PTF) on COVID-19 media briefing, Fiona Braka, the officer in charge, WHO Nigeria, said drug trials would soon begin in the country.
According to Braka, more than 100 countries have joined the solidarity clinical trial, which was launched by WHO and some partners, to help find an effective treatment for COVID-19.
Speaking at the daily briefing of the Presidential Task Force (PTF) on COVID-19 in Abuja, the Minister of Health, Dr. Osagie Ehanire, stated that ethical standards will be maintained for Nigerians safety.
He said: “We have indicated interest to the WHO to be part of the global solidarity trial of medicines being tried to tackle the COVID-19 pandemic, and efforts on to also conduct research here in Nigeria. Other drugs can be added to the trials based on emerging evidence.
“In all this, we shall ensure the maintenance of ethical standards and safety of our people.”